Cell Transformation by c-fos Requires an Extended Period of Expression and Is Independent of the Cell Cycle

REFERENCES

• Abate, C., F. J. RauscherIII, R. Gentz, and T. Curran. 1990. Expression and purification of the leucine zipper and the DNA-binding domains of Fos and Jun: both Fos and Jun directly contact DNA. Proc. Natl. Acad. Sci. USA 87: 1032–1036.
   PubMed Web of Science ®Google Scholar
• Auvinen, M., A. Paasinen, L. C. Andersson, and E. Holtta. 1992. Ornithine decarboxylase activity is critical for cell transformation. Nature (London) 360: 355–358.
   PubMed Web of Science ®Google Scholar
• Bell, J. G., J. A. Wyke, and I. A. MacPherson. 1975. Transformation by a temperature sensitive mutant of Rous sarcoma virus in the absence of serum. J. Gen. Virol. 27: 127–134.
   PubMedGoogle Scholar
• Bravo, R., J. Burckhardt, T. Curran, and R. Muller. 1986. Expression of c-fos in NIH3T3 cells is very low but inducible throughout the cell cycle. EMBO J. 5: 695–700.
   PubMedGoogle Scholar
• Breathnach, R. 1991. Matrix metalloproteinases and tumor invasion, p. 825–831. In J. Brugge, T. Curran, E. Harlow, and F. McCormick (ed.), Origins of human cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Brown, P. H., R. Alani, L. H. Preis, E. Szabo, and M. J. Birrer. 1993. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 8: 877–886.
   PubMed Web of Science ®Google Scholar
• Catling, A. D., J. A. Wyke, and M. C. Frame. 1993. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1. Oncogene 8: 1875–1886.
   PubMedGoogle Scholar
• Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7: 2745–2752.
   PubMed Web of Science ®Google Scholar
• Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156–159.
   PubMed Web of Science ®Google Scholar
• Cohen, D. R., and T. Curran. 1990. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside of the leucine zipper/basic region. Oncogene 5: 929–939.
   PubMed Web of Science ®Google Scholar
• Curran, T. 1982. Ph.D. thesis. University of London, London, England.
   Google Scholar
• Curran, T. 1988. The fos oncogene, p. 307–325. In E. P. Reddy, A. M. Skalka, and T. Curran (ed.), The oncogene handbook. Elsevier, Amsterdam.
   Google Scholar
• Curran, T., A. D. Miller, L. Zokas, and I. M. Verma. 1984. Viral and cellular fos proteins: a comparative analysis. Cell 36: 259–268.
   PubMed Web of Science ®Google Scholar
• Curran, T., G. Peters, C. Van Beveren, N. M. Teich, and I. M. Verma. 1982. FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J. Virol. 44: 674–682.
   PubMed Web of Science ®Google Scholar
• Curran, T., and N. M. Teich. 1982. Candidate product of the FBJ murine osteosarcoma virus oncogene: characterization of a 55,000-dalton phosphoprotein. J. Virol. 42: 114–122.
   PubMedGoogle Scholar
• Curran, T., and N. M. Teich. 1982. Identification of a 39,000-dalton protein in cells transformed by the FBJ murine osteosarcoma virus. Virology 116: 221–235.
   PubMed Web of Science ®Google Scholar
• Curran, T., and I. M. Verma. 1984. FBR murine osteosarcoma virus. I. Molecular analysis and characterization of a 75,000-dalton gag-fos fusion product. Virology 135: 218–228.
   Google Scholar
• Curran, T., and P. K. Vogt. 1992. Dangerous liaisons: Fos and Jun, oncogenic transcription factors, p. 797–831. In S. L. McKnight, and K. R. Yamamoto (ed.), Transcriptional regulation, book 2. Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Everts, V., J. M. Delaisse, W. Korper, A. Niehof, G. Vaes, and W. Beertsen. 1992. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine proteinases and matrix metalloproteinases. J. Cell. Physiol. 150: 221–231.
   PubMed Web of Science ®Google Scholar
• Field, S. J., R. S. Johnson, R. M. Mortensen, V. E. Papaioannou, B. M. Spiegelman, and M. E. Greenberg. 1992. Growth and differentiation of embryonic stem cells that lack an intact c-fos gene. Proc. Natl. Acad. Sci. USA 89: 9306–9310.
   PubMedGoogle Scholar
• Finkel, M. P., B. O. Biskis, and P. B. Jinkins. 1966. Virus induction of osteosarcomas in mice. Science 151: 698–701.
   PubMed Web of Science ®Google Scholar
• Finkel, M. P., C. A. ReillyJr., and B. O. Biskis. 1975. Viral etiology of bone cancer. Front. Radiat. Ther. Oncol. 10: 28–39.
   Google Scholar
• Franza, B. R.Jr., L. C. Sambucetti, D. R. Cohen, and T. Curran. 1987. Analysis of Fos protein complexes and Fos-related antigens by high-resolution two-dimensional gel electrophoresis. Oncogene 1: 213–221.
   PubMed Web of Science ®Google Scholar
• Friis, R. R., B. M. Jockusch, C. B. Boschek, A. Ziemiecki, H. Rubsamen, and H. Bauer. 1980. Transformation-defective, temperature-sensitive mutants of Rous sarcoma virus have a reversibly defective src-gene product. Cold Spring Harbor Symp. Quant. Biol. 44: 1007–1012.
   PubMedGoogle Scholar
• Fujii, M., D. Shalloway, and I. M. Verma. 1989. Gene regulation by tyrosine kinases: Src protein activates various promoters, including c-fos. Mol. Cell. Biol. 9: 2493–2499.
   Google Scholar
• Gauthier-Rouviere, C., A. Fernandez, and N. J. C. Lamb. 1990. ras-induced c-fos expression and proliferation in living rat fibroblasts involves C-kinase activation and the serum response element pathway. EMBO J. 9: 171–180.
   PubMedGoogle Scholar
• Gentz, R., F. J. RauscherIII, C. Abate, and T. Curran. 1989. Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains. Science 243: 1695–1699.
   PubMed Web of Science ®Google Scholar
• Greenberg, M. E., and E. B. Ziff. 1984. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (London) 311: 433–438.
   PubMed Web of Science ®Google Scholar
• Grigoriadis, A. E., K. Schellander, Z.-Q. Wang, and E. F. Wagner. 1993. Osteoblasts are target cells for transformation in c-fos transgenic mice. J. Cell Biol. 122: 685–701.
   PubMed Web of Science ®Google Scholar
• Hawker, K. L., A. Pintzas, R. F. Hennigan, D. A. F. Gillespie, and B. W. Ozanne. 1993. Transformation by fos or jun oncogenes does not increase AP-1 DNA-binding activity. J. Virol. 67: 5487–5495.
   PubMedGoogle Scholar
• Heby, O., and L. Persson. 1990. Molecular genetics of polyamine synthesis in eucaryotic cells. Trends Biochem. Sci. 15: 153–158.
   PubMed Web of Science ®Google Scholar
• Holt, J. T., T. V. Gopal, A. D. Moulton, and A. W. Nienhuis. 1986. Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc. Natl. Acad. Sci. USA 83: 4794–4798.
   PubMed Web of Science ®Google Scholar
• Holtta, E., M. Auvinen, and L. C. Andersson. 1993. Polyamines are essential for cell transformation by pp60v-src: delineation of molecular events relevant for the transformed phenotype. J. Cell Biol. 122: 903–914.
   PubMedGoogle Scholar
• Holtta, E., L. Sistonen, and K. Alitalo. 1988. The mechanisms of ornithine decarboxylase deregulation in c-Ha-ras-oncogene-trans-formed NIH3T3 cells. J. Biol. Chem. 263: 4500–4507.
   PubMedGoogle Scholar
• Jamal, S., and E. Ziff. 1990. Transactivation of c-fos and β-actin genes as a step in early response to transmembrane signals. Nature (London) 344: 463–466.
   PubMed Web of Science ®Google Scholar
• Jenuwein, T., D. Muller, T. Curran, and R. Muller. 1985. Extended life span and tumorigenicity of nonestablished mouse connective tissue cells transformed by the fos oncogene of FBR-MuSV. Cell 41: 629–637.
   PubMed Web of Science ®Google Scholar
• Jenuwein, T., and R. Muller. 1987. Structure-function analysis of Fos protein: a single amino acid change activates the immortalizing potential of v-fos. Cell 48: 647–657.
   PubMedGoogle Scholar
• Johnson, R. S., B. M. Spiegelman, and V. Papaioannou. 1992. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71: 577–586.
   PubMed Web of Science ®Google Scholar
• Kerr, L. D., J. T. Holt, and L. M. Matrisian. 1988. Growth factors regulate transin gene expression by c-fos-dependent and fos-independent pathways. Science 242: 1424–1427.
   PubMed Web of Science ®Google Scholar
• Kouzarides, T., and E. Ziff. 1988. The role of the leucine zipper in the fos-jun interaction. Nature (London) 336: 646–651.
   PubMed Web of Science ®Google Scholar
• Kovary, K., and R. Bravo. 1991. The Jun and Fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11: 4466–4472.
   PubMed Web of Science ®Google Scholar
• Kovary, K., and R. Bravo. 1992. Existence of different Fos/Jun complexes during the GO-to-Gl transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins. Mol. Cell. Biol. 12: 5015–5023.
   PubMedGoogle Scholar
• Kruijer, W., J. A. Cooper, T. Hunter, and I. M. Verma. 1984. Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature (London) 312: 711–716.
   PubMed Web of Science ®Google Scholar
• Labow, M. A., S. B. Baim, T. Shenk, and A. J. Levine. 1990. Conversion of the lac repressor into an allosterically regulated transcriptional activator for mammalian cells. Mol. Cell. Biol. 10: 3343–3356.
   PubMedGoogle Scholar
• Landschulz, W. H., P. F. Johnson, and S. L. McKnight. 1988. The leucine zipper: a hypothetical structure common to a new class of DNA-binding proteins. Science 240: 1759–1764.
   PubMed Web of Science ®Google Scholar
• Lloyd, A., N. Yancheva, and B. Wasylyk. 1991. Transformation suppressor activity of a Jun transcription factor lacking its activation domain. Nature (London) 352: 635–638.
   PubMedGoogle Scholar
• Lloyd, A. C., H. F. Paterson, J. D. H. Morris, A. Hall, and C. J. Marshall. 1989. p21H-ras-induced morphological transformation and increases in c-myc expression are independent of functional protein kinase C. EMBO J. 8: 1099–1104.
   PubMedGoogle Scholar
• Marshall, C. J. 1990. How does p21ras transform cells? Trends Genet. 7: 91–95.
   Google Scholar
• Martin, G. S., S. Venuta, M. Weber, and H. Rubin. 1971. Temperature-dependent alterations in sugar transport in cells infected by a temperature-sensitive mutant of Rous sarcoma virus. Proc. Natl. Acad. Sci. USA 68: 2739–2741.
   PubMed Web of Science ®Google Scholar
• Matrisian, L. M., G. T. Bowden, P. Krieg, G. Furstenberger, J. P. Briand, P. Leroy, and R. Breathnach. 1986. The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc. Natl. Acad. Sci. USA 83: 9413–9417.
   PubMed Web of Science ®Google Scholar
• Matrisian, L. M., N. Glaichenhaus, M. C. Gesnel, and R. Breathnach. 1985. Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EMBO J. 4: 1435–1440.
   PubMed Web of Science ®Google Scholar
• McDonnell, S. E., L. D. Kerr, and L. M. Matrisian. 1990. Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C. Mol. Cell. Biol. 10: 4284–4293.
   PubMedGoogle Scholar
• Meijlink, F., T. Curran, A. D. Miller, and I. M. Verma. 1985. Removal of a 67 base pair sequence in the noncoding region of proto-oncogene fos converts it to a transforming gene. Proc. Natl. Acad. Sci. USA 82: 4987–4991.
   PubMed Web of Science ®Google Scholar
• Miller, A. D., T. Curran, and I. M. Verma. 1984. c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell 36: 259–268.
   PubMedGoogle Scholar
• Morgan, J. I., and T. Curran. 1991. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Ann. Rev. Neurosci. 14: 421–451.
   Google Scholar
• Morris, J. D. H., B. Price, A. C. Lloyd, A. J. Self, C. J. Marshall, and A. Hall. 1989. Scrape-loading of Swiss 3T3 cells with ras protein rapidly activates protein kinase C in the absence of phosphoinositide hydrolysis. Oncogene 4: 27–31.
   PubMed Web of Science ®Google Scholar
• Muller, R., R. Bravo, J. Burchkhardt, and T. Curran. 1984. Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature (London) 312: 716–720.
   PubMed Web of Science ®Google Scholar
• Nakabeppu, Y., S. Oda, and M. Sekiguchi. 1993. Proliferative activation of quiescent Rat-la cells by AFosB. Mol. Cell. Biol. 13: 4157–4166.
   PubMedGoogle Scholar
• Neuberg, M., M. Schuermann, and R. Muller. 1991. Mutagenesis of the DNA contact site in Fos protein: compatibility with the scissors grip model and requirement for transformation. Oncogene 6: 1325–1333.
   PubMedGoogle Scholar
• Nishikura, K., and J. M. Murray. 1987. Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiscent 3T3 cells. Mol. Cell. Biol. 7: 639–649.
   PubMed Web of Science ®Google Scholar
• Nishizawa, M., N. Goto, and S. Kawai. 1987. An avian transforming retrovirus isolated from a nephroblastoma that carries the fos gene as the oncogene. J. Virol. 16: 3733–3740.
   Google Scholar
• Papavassiliou, A. G., M. Treier, C. Chavrier, and D. Bohmann. 1992. Targeted degradation of c-Fos, but not v-Fos, by a phos-phorylation-dependent signal on c-Jun. Science 258: 1941–1944.
   PubMedGoogle Scholar
• Patwardhan, S., A. Gashler, M. G. Siegel, L. C. Chang, L. J. Joseph, T. B. Shows, M. M. Le Beau, and V. P. Sukhatme. 1991. EGR-3, a novel member of the Egr family of genes encoding immediate-early transcription factors. Oncogene 6: 917–928.
   PubMed Web of Science ®Google Scholar
• Picard, D. 1993. Steroid-binding domains for regulating the functions of heterologous proteins in cis. Trends Cell Biol. 3: 278–280.
   PubMedGoogle Scholar
• Quade, K. 1979. Transformation of mammalian cells by avian myelocytomatosis and avian erythroblastosis virus. Virology 98: 461–465.
   PubMedGoogle Scholar
• Rauscher, F. J.III, L. C. Sambucetti, T. Curran, R. J. Distel, and B. M. Spiegelman. 1988. A common DNA binding site for Fos protein complexes and transcriptional factor AP-1. Cell 52: 471–480.
   PubMed Web of Science ®Google Scholar
• Reddy, E. P., A. M. Skalka, and T. Curran (ed.). 1988. The oncogene handbook. Elsevier, Amsterdam.
   Google Scholar
• Riabowol, K. T., R. J. Vosatka, E. B. Ziff, N. J. Lamb, and J. R. Feramisco. 1988. Microinjection of fos-specific antibodies blocks DNA synthesis in fibroblast cells. Mol. Cell. Biol. 8: 1670–1676.
   PubMed Web of Science ®Google Scholar
• Rohrschneider, L. R. 1980. Localization of pp60src with normal rat kidney cells infected with temperature-sensitive mutants (T-class) of Rous sarcoma virus. Cold Spring Harbor Symp. Quant. Biol. 44: 1013–1022.
   PubMedGoogle Scholar
• Samuels, M. L., M. J. Weber, J. M. Bishop, and M. McMahon. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 protein kinase. Mol. Cell. Biol. 13: 6241–6252.
   PubMedGoogle Scholar
• Schonthal, A., H. J. Herrlich, P. Rhamsdorf, and H. Ponta. 1988. Requirements for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 54: 325–334.
   PubMed Web of Science ®Google Scholar
• Schuermann, M., G. Hennig, and R. Muller. 1993. Transcriptional activation and transformation by chimaeric Fos-estrogen receptor proteins: altered properties as a consequence of gene fusion. Oncogene 8: 2781–2790.
   PubMedGoogle Scholar
• Schuermann, M., K. Jooss, and R. Muller. 1991. fosB is a transforming gene encoding a transcriptional activator. Oncogene 6: 567–576.
   PubMedGoogle Scholar
• Schuermann, M., M. Neuberg, J. B. Hunter, T. Jenuwein, R.-P. Ryseck, R. Bravo, and R. Muller. 1989. The leucine zipper motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation. Cell 56: 507–516.
   PubMedGoogle Scholar
• Smeyne, R. J., K. Schilling, L. Robertson, D. Luk, J. Oberdick, T. Curran, and J. I. Morgan. 1992. Fos-lac Z transgenic mice: mapping sites of gene induction in the central nervous system. Neuron 8: 13–23.
   PubMed Web of Science ®Google Scholar
• Smeyne, R. J., M. Vendrell, M. Hayward, S. J. Baker, G. G. Miao, K. Schilling, L. Roberston, T. Curran, and J. I. Morgan. 1993. Continuous c-fos expression precedes programmed cell death in vivo. Nature (London) 363: 166–169.
   PubMed Web of Science ®Google Scholar
• Stacey, D. W., and H. Kung. 1984. Transformation of NIH3T3 cells by microinjection of Ha-ras p21 protein. Nature (London) 310: 508–511.
   PubMed Web of Science ®Google Scholar
• Stacey, D. W., T. Watson, H.-F. Kung, and T. Curran. 1987. Microinjection of transforming ras protein induces c-fos expression. Mol. Cell. Biol. 7: 523–527.
   PubMedGoogle Scholar
• Superti-Furga, G., G. Bergers, D. Picard, and M. Busslinger. 1991. Hormone-dependent transcriptional regulation and cellular transformation by Fos-steroid receptor fusion proteins. Proc. Natl. Acad. Sci. USA 88: 5114–5118.
   PubMedGoogle Scholar
• Suzuki, T., M. Murakami, N. Onai, E. Fukuda, Y. Hashimoto, M. H. Sonobe, T. Kameda, M. Ichinose, K. Miki, and H. Iba. 1994. Analysis of AP-1 function in cellular transformation pathways. J. Virol. 68: 3527–3535.
   PubMed Web of Science ®Google Scholar
• Thayer, M. J., and H. Weintraub. 1993. A cellular factor stimulates the DNA-binding activity of MyoD and E47. Proc. Natl. Acad. Sci. USA 90: 6483–6487.
   PubMedGoogle Scholar
• Turner, R., and R. Tjian. 1989. Leucine repeats and an adjacent DNA-binding domain mediate the formation of functional c-fos-cjun heterodimers. Science 243: 1689–1694.
   PubMed Web of Science ®Google Scholar
• Wang, Z., A. Grigoriadis, U. Mohle-Steinlein, and E. F. Wagner. 1991. A novel target cell for c-fos-induced oncogenesis: development of chondrogenic tumors in embryonic stem cell chimeras. EMBO J. 10: 2437–2450.
   PubMedGoogle Scholar
• Wang, Z., C. Ovitt, A. E. Grigoriadis, U. Mohle-Steinlein, U. Ruther, and E. F. Wagner. 1992. Bone and haematopoietic defects in mice lacking c-fos. Nature (London) 360: 741–745.
   PubMed Web of Science ®Google Scholar
• Wick, M., F. C. Lucibello, and R. Muller. 1992. Inhibition of Fos-and Ras-induced transformation by mutant Fos proteins with structural alterations in functionally different domains. Oncogene 7: 859–867.
   PubMedGoogle Scholar
• Wisdom, R., and I. M. Verma. 1993. Transformation by Fos proteins requires a C-terminal transactivation domain. Mol. Cell. Biol. 13: 7429–7438.
   PubMed Web of Science ®Google Scholar
• Wrighton, C., and M. Busslinger. 1993. Direct transcription stimulation of the ornithine decarboxylase gene by Fos in PC 12 cells but not in fibroblasts. Mol. Cell. Biol. 13: 4657–4669.
   PubMed Web of Science ®Google Scholar
• Wyborski, D. L., and J. M. Short. 1991. Analysis of inducers of the E. coli lac repressor system in mammalian cells and whole animals. Nucleic Acids Res. 19: 4647–4653.
   PubMedGoogle Scholar
• Wyke, A. W., W. Cushley, and J. A. Wyke. 1993. Mitogenesis by v-src: a need for active oncoprotein both in leaving GO and in completing Gl phases of the cell cycle. Cell Growth Differ. 4: 671–678.
   PubMedGoogle Scholar
• Xanthoudakis, S., G. G. Miao, F. Wang, Y.-C. E. Pan, and T. Curran. 1992. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 11: 3323–3335.
   PubMed Web of Science ®Google Scholar
• Yoshida, T., Y. Shindo, K. Ohta, and H. Iba. 1989. Identification of a small region of the v-fos gene product that is sufficient for transforming potential and growth stimulating activity. Oncogene Res. 5: 79–89.
   PubMedGoogle Scholar
• Zambetti, G. P., D. Olson, M. A. Labow, and A. J. Levine. 1992. A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNA. Proc. Natl. Acad. Sci. USA 89: 3952–3956.
   PubMedGoogle Scholar